Back to CVE records
High 7.3Published Sep 29, 2026

CVE-2026-102491mahonelau kykms SqlInjectionUtil QueryGenerator.java QueryGenerator.doMultiFieldsOrder sql injection

Updated under an hour ago ()

Does this affect you?

It affects mahonelau kykms. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.25%, higher than 16% of scored CVEs.

A vulnerability was identified in mahonelau kykms up to 8f130c2d85842d5b44caae78cc46d65e505949f7. The impacted element is the function QueryGenerator.doMultiFieldsOrder of the file QueryGenerator.java of the component SqlInjectionUtil. The manipulation of the argument column leads to sql injection. Remote exploitation of the attack is possible. The exploit is publicly available and might be used. This product follows a rolling release approach for continuous delivery, so version details for affected or updated releases are not provided. The vendor was contacted early about this disclosure but did not respond in any way.

CVSS
7.3 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L/E:P/RL:X/RC:C
Weakness (CWE)
CWE-89, CWE-74
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.25% (percentile 16)
Assigned by
VulDB
NVD analysis
Deferred
Record last updated
Sep 29, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
mahonelau kykms
mahonelau:kykms
8f130c2d85842d5b44caae78cc46d65e505949f7
CNA record

References

  • vdb-entry, technical-description
  • signature, permissions-required
  • third-party-advisory
  • third-party-advisory
  • exploit

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.